![D. Walke](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/m.png)
D. Walke
Investor Relations Contact at IONIS PHARMACEUTICALS, INC.
Profile
D.
Wade Walke is the founder of Ionis Pharmaceuticals, Inc. founded in 2012, where he held the title of VP-Corporate Communications & Investor Relations from 2012 to 2018.
Currently, he holds the position of Senior Vice President-Investor Relations at Ionis Pharmaceuticals, Inc. since 2023 and Vice President-Investor Relations at 23andMe, Inc. since 2021.
Previously, he worked as Senior Director-Investor & Media Relations Contact at Lexicon Pharmaceuticals, Inc. from 2011 to 2012 and as Vice President-Investor Relations at 23andMe Holding Co. from 2021 to 2022.
Dr. Walke completed his undergraduate degree at Brigham Young University and his graduate and doctorate degrees at the University of Michigan.
D. Walke active positions
Companies | Position | Start |
---|---|---|
IONIS PHARMACEUTICALS, INC. | Investor Relations Contact | 31/12/2022 |
23andMe, Inc.
![]() 23andMe, Inc. Medical SpecialtiesHealth Technology 23andMe, Inc. provides genetic information using DNA analysis technologies and web-based interactive tools. It enables individuals to gain deeper insights into personal ancestry, genealogy, and inherited traits. The company was founded by Linda Avey, Paul L. Cusenza and Anne E. Wojcicki in 2006 and is headquartered in Sunnyvale, CA. | Investor Relations Contact | 31/05/2021 |
Former positions of D. Walke
Companies | Position | End |
---|---|---|
23ANDME HOLDING CO. | Investor Relations Contact | 31/05/2022 |
IONIS PHARMACEUTICALS, INC. | Founder | 30/06/2018 |
LEXICON PHARMACEUTICALS, INC. | Investor Relations Contact | - |
Training of D. Walke
Brigham Young University | Undergraduate Degree |
University of Michigan | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 3 |
---|---|
IONIS PHARMACEUTICALS, INC. | Health Technology |
LEXICON PHARMACEUTICALS, INC. | Health Technology |
23ANDME HOLDING CO. | Health Technology |
Private companies | 1 |
---|---|
23andMe, Inc.
![]() 23andMe, Inc. Medical SpecialtiesHealth Technology 23andMe, Inc. provides genetic information using DNA analysis technologies and web-based interactive tools. It enables individuals to gain deeper insights into personal ancestry, genealogy, and inherited traits. The company was founded by Linda Avey, Paul L. Cusenza and Anne E. Wojcicki in 2006 and is headquartered in Sunnyvale, CA. | Health Technology |
- Stock Market
- Insiders
- D. Walke